-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S.-LISTED SHARES OF BIONTECH UP 17%, NOVAVAX RISE 4.5% AFTER MODERNA AND MERCK'S SKIN CANCER VACCINE SUCCEEDS IN LATE-STAGE TRIAL

Reuters·08/19/2026 13:33:36

Please log in to view news